Alzheimer-associated neuronal thread protein-induced apoptosis and impaired mitochondrial function in human central nervous system-derived neuronal cells

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 2, 2001, Pages 195-207

  De La Monte, Suzanne M ^a   Wands, Jack R ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Apoptosis; Inducible gene expression; Mitochondria; Neuronal thread protein

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN PROTEIN; FAS ANTIGEN; GENE PRODUCT; NEURONAL THREAD PROTEIN; PROTEIN P53; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CELL DEATH; CELL LOSS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION FUNCTION; DEGENERATIVE DISEASE; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; SYNAPSE;

EID: 0035113832     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.2.195     Document Type: Article

References (64)

1. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay
2. Evidence for apoptotic cell death in Alzheimer's disease
3. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease
4. p53- and CD95-associated apoptosis in neurodegenerative diseases
5. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
6. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
7. Immunohisto-chemical evidence for apoptosis in Alzheimer's disease
8. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus
9. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease
10. Fas antigen expression in brains of patients with Alzheimer-type dementia
11. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35
12. Beta-Amyloid neurotoxicity
13. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments
14. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice
15. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype
16. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP
17. Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons
18. G protein betagamma complex-mediated apoptosis by familial Alzheimer's disease mutant of APP
19. Mechanism of amyloid beta protein induced neuronal cell death: Current concepts and future perspectives
20. The role of iron in beta amyloid toxicity
21. Neurodegenerative mechanisms in Alzheimer disease. A role for oxidative damage in amyloid beta protein precursor-mediated cell death
22. Neurodegeneration mediated by glutamate and beta-amyloid peptide: A comparison and possible interaction
23. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide
24. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals
25. Mechanisms of cell death in Alzheimer's disease
26. Mitochondria, free radicals, and neurodegeneration
27. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease
28. Oxidative stress: Free radical production in neural degeneration
29. Oxidative stress in Parkinson's disease and other neuro-degenerative disorders
30. Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type
31. Oxidative stress hypothesis in Alzheimer's disease
32. The effects of aging and neurodegeneration on apoptosis-associated DNA fragmentation and the benefits of nicotinamide
33. Metals and free radicals in neurode-generation
34. Oxidative stress in neurodegenerative diseases
35. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease
36. Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in CNS neurons
37. Oxygen free radical injury is sufficient to cause some Alzheimer-type molecular abnormalities in human CNS neuronal cells
38. Characterization of the AD7c-NTP cDNA expression in Alzheimer's disease and measurement of the 41-kD protein in cerebrospinal fluid
39. Profiles of neuronal thread protein expression in Alzheimer's disease
40. Neurofibromatosis type 1 gene mutations in neuroblastoma
41. Competition studies with repressors and activators of viral enhancer function in F9 mouse embryonal carcinoma cells
42. Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation
43. A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: Characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases
44. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma
45. Superoxide anion is a natural inhibitor of FAS-mediated cell death
46. Analysis of apoptosis-associated DNA fragmentation in vivo during neurodegeneration of the peripheral ol-factory system in adult mammals
47. A novel method for quantitative analysis of apoptosis
48. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells
49. Microtiter Immunocytochemical ELISA Assay: A Novel and highly sensitive method of quantifying immunoreactivity
50. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells
51. Neuronal thread protein gene modulation with cerebral infarction
52. Insulin-induced differentiation and modulation of neuronal thread protein expression in primitive neuroectodermal tumor cells is linked to phosphorylation of insulin receptor substrate-1
53. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice
54. Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization
55. Neurotoxicity of beta-amyloid protein: Cytochemical changes and apoptotic cell death investigated in organotypic cultures
56. Aberrant expression of nitric oxide synthase III in Alzheimer's disease: Relevance to cerebral vasculopathy and neurodegeneration
57. Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology
58. Bcl-2 and Bax protein expression in Alzheimer's disease
59. Apoptosis of cerebellar granule cells induced by serum withdrawal, glutamate or beta-amyloid, is independent of Jun kinase or p38 mitogen activated protein kinase activation
60. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons
61. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: A critical appraisal
62. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons
63. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: A chronic oxidative paradigm for testing antioxidant therapies in vivo